First real-life experiences with 2 mg bulevirtide for the treatment of hepatitis delta-data from a tertiary reference centre in Germany

被引：0
|
作者：
Zoellner, Caroline [1 ,2 ]
Lutz, Katrin [1 ,2 ]
Demir, Muenevver [1 ,2 ]
Tacke, Frank [1 ,2 ]
机构：
[1] Charite Univ Med Berlin, Dept Gastroenterol & Hepatol, Campus Virchow Klinikum, Berlin, Germany
[2] Charite Univ Med Berlin, Dept Gastroenterol & Hepatol, Charite Campus Mitte, Berlin, Germany
来源：
JOURNAL OF HEPATOLOGY | 2021年 / 75卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
PO-1419
引用
收藏
页码：S745 / S746
页数：2
相关论文
共 50 条
  • [1] Real-life experiences with bulevirtide for the treatment of hepatitis delta-48 weeks data from a German centre
    Zoellner, Caroline
    Hofmann, Joerg
    Lutz, Katrin
    Tacke, Frank
    Demir, Muenevver
    LIVER INTERNATIONAL, 2022, 42 (11) : 2403 - 2407
  • [2] Bulevirtide 2 mg/day monotherapy in patients with chronic hepatitis delta with or without cirrhosis: a multicenter european cohort real-life study
    Loglio, Alessandro
    Ferenci, Peter
    Deterding, Katja
    Renteria, Sara Colonia Uceda
    Sambarino, Dana
    Jachs, Mathias
    Schwarz, Caroline
    Borghi, Marta
    Port, Kerstin
    Perbellini, Riccardo
    Facchetti, Floriana
    Degasperi, Elisabetta
    Maasoumy, Benjamin
    Reiberger, Thomas
    Cornberg, Markus
    Wedemeyer, Heiner
    Lampertico, Pietro
    JOURNAL OF HEPATOLOGY, 2022, 77 : S843 - S843
  • [3] Bulevirtide 2mg-based real-life treatment of hepatitis Delta with genotypes 1 and 5 viruses at more than 20 months of follow-up
    Dassetto, Clara
    Borentain, Patrick
    Gerolamia, Rene
    Colson, Philippe
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2022, 46 (10)
  • [4] Embryonal and Alveolar Rhabdomyosarcoma in Adults: Real-Life Data From a Tertiary Sarcoma Centre
    Drabbe, C.
    Benson, C.
    Younger, E.
    Zaidi, S.
    Jones, R. L.
    Judson, I
    Chisholm, J.
    Mandeville, H.
    Fisher, C.
    Thway, K.
    Al Muderis, O.
    Messiou, C.
    Strauss, D.
    Husson, O.
    Miah, A.
    Van der Graaf, W. T. A.
    CLINICAL ONCOLOGY, 2020, 32 (01) : E27 - E35
  • [5] JAK2-negative polyglobulia - real life data of 10 years from a tertiary reference centre
    Jalowiec, K. A.
    Frey, N.
    Capraru, A.
    Wojtovicova, T.
    Joncourt, R.
    Tichelli, A.
    Porret, N. A.
    Rovo, A.
    SWISS MEDICAL WEEKLY, 2020, : 15S - 16S
  • [6] Treatment strategies for hidradenitis suppurativa: real-life data from a tertiary Greek hospital
    Aikaterini Tsentemeidou
    Elena Sotiriou
    Efstratios Vakirlis
    Nikolaos Sideris
    Aimilios Lallas
    Demeter Ioannides
    Archives of Dermatological Research, 2022, 314 : 301 - 305
  • [7] Treatment strategies for hidradenitis suppurativa: real-life data from a tertiary Greek hospital
    Tsentemeidou, Aikaterini
    Sotiriou, Eleni
    Vakirlis, Eustratios
    Sideris, Nikolaos
    Lallas, Aimilios
    Ioannides, Dimitrios
    EXPERIMENTAL DERMATOLOGY, 2020, 29 : 48 - 48
  • [8] Treatment strategies for hidradenitis suppurativa: real-life data from a tertiary Greek hospital
    Tsentemeidou, Aikaterini
    Sotiriou, Elena
    Vakirlis, Efstratios
    Sideris, Nikolaos
    Lallas, Aimilios
    Ioannides, Demeter
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 2022, 314 (03) : 301 - 305
  • [9] Real-life efficacy of biologicals in patients with severe asthma phenotype overlap. Experiences from a tertiary pulmonary centre
    Sleiman, Y.
    Lacwik, P.
    Moscicka, A.
    Ochab-Krupnik, D.
    Palczynski, C.
    ALLERGY, 2023, 78
  • [10] Sustained virological response after treatment with Bulevirtide in HDV patients. Data from the french multicenter real-life cohort
    de Ledinghen, Victor
    Lacombe, Karine
    Pol, Stanislas
    Alric, Laurent
    Lascoux-Combe, Caroline
    Alfaiate, Dulce
    Hilleret, Marie-Noelle
    Ganne-Carrie, Nathalie
    Gournay, Jerome
    Loustaud-Ratti, Veronique
    Subic-Levrero, Miroslava
    Coulibaly, Fatoumata
    Le Pabic, Estelle
    Tual, Christelle
    Brichler, Segolene
    Zoulim, Fabien
    JOURNAL OF HEPATOLOGY, 2024, 80 : S802 - S802
12345